G1 Therapeutics Ownership 2024 | Who Owns G1 Therapeutics Now?
Institutional Ownership
12.09%
Insider Ownership
10.92%
Retail Ownership
76.99%
Institutional Holders
32.00
G1 Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.91% | 0.00% | 3,082,031 | 2,410,004 | 358.62% | 7,027,030 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.77% | 0.00% | 2,491,109 | 409,536 | 19.67% | 5,679,729 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.61% | 0.03% | 1,362,354 | 1,362,354 | 100.00% | 3,106,167 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.39% | 0.00% | 1,245,180 | 341,480 | 37.79% | 2,839,010 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.07% | 0.00% | 1,079,645 | 573,840 | 113.45% | 2,462,179 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.78% | 0.01% | 928,205 | 494,496 | 114.02% | 2,114,000 | Jun 30, 2024 |
| STATE STREET CORP | 1.59% | 0.00% | 827,956 | 666,850 | 413.92% | 1,887,740,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.53% | 0.00% | 800,511 | 476,045 | 146.72% | 1,825,165 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 1.53% | 0.00% | 797,677 | -5,158 | -0.64% | 1,818,704 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.47% | 0.00% | 767,066 | -18,193 | -2.32% | 1,748,910 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 1.10% | 0.01% | 576,354 | 162,775 | 39.36% | 1,314,087 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.89% | 0.00% | 463,593 | 85,735 | 22.69% | 1,056,992 | Jun 30, 2024 |
| ABRDN PLC | 0.81% | 0.00% | 423,869 | - | - | 966,421 | Jun 30, 2024 |
| MORGAN STANLEY | 0.77% | 0.00% | 401,481 | 226,144 | 128.98% | 915,376 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.76% | 0.02% | 398,043 | 206,900 | 108.24% | 907,538 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.71% | 0.02% | 368,000 | 368,000 | 100.00% | 839,040 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.67% | 0.02% | 349,100 | 349,100 | 100.00% | 795,948 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.61% | 0.01% | 320,800 | 141,400 | 78.82% | 731,424 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.59% | 0.00% | 308,825 | -25,306 | -7.57% | 704,121 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.40% | 0.00% | 210,623 | -237,338 | -52.98% | 480,220 | Jun 30, 2024 |
G1 Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 5.91% of the company's total share outstanding, currently valued at $7.03M. The top 10 institutional shareholders own together 25.65% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 0.02% | 0.51% | 12,864 | 12,864 | 100.00% | 2,932,992 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.02% | 0.49% | 12,248 | 12,248 | 100.00% | 2,792,544 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.15% | 0.17% | 80,000 | - | - | 182,400 | Jun 30, 2024 |
| FINTRUST CAPITAL ADVISORS, LLC | 0.19% | 0.04% | 100,780 | - | - | 229,779 | Jun 30, 2024 |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 0.34% | 0.03% | 180,000 | - | - | 410,400 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.38% | 0.03% | 199,963 | 199,963 | 100.00% | 455,916 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.61% | 0.03% | 1,362,354 | 1,362,354 | 100.00% | 3,106,167 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.76% | 0.02% | 398,043 | 206,900 | 108.24% | 907,538 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.71% | 0.02% | 368,000 | 368,000 | 100.00% | 839,040 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.67% | 0.02% | 349,100 | 349,100 | 100.00% | 795,948 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.09% | 0.02% | 46,728 | 46,728 | 100.00% | 106,540 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 0.38% | 0.01% | 199,358 | 199,358 | 100.00% | 454,536 | Jun 30, 2024 |
| FRANKLIN STREET ADVISORS INC /NC | 0.16% | 0.01% | 83,400 | - | - | 190,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.14% | 0.01% | 74,354 | 74,354 | 100.00% | 170,000 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.61% | 0.01% | 320,800 | 141,400 | 78.82% | 731,424 | Jun 30, 2024 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 0.08% | 0.01% | 40,805 | 300 | 0.74% | 93,035 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.37% | 0.01% | 191,000 | 101,300 | 112.93% | 435,480 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.36% | 0.01% | 185,505 | 87,937 | 90.13% | 422,951 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.78% | 0.01% | 928,205 | 494,496 | 114.02% | 2,114,000 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 1.10% | 0.01% | 576,354 | 162,775 | 39.36% | 1,314,087 | Jun 30, 2024 |
The largest G1 Therapeutics shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 12.86K shares of G1 Therapeutics (GTHX), representing 0.51% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.91% | 0.00% | 3,082,031 | 2,410,004 | 358.62% | 7,027,030 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.61% | 0.03% | 1,362,354 | 1,362,354 | 100.00% | 3,106,167 | Jun 30, 2024 |
| STATE STREET CORP | 1.59% | 0.00% | 827,956 | 666,850 | 413.92% | 1,887,740,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.07% | 0.00% | 1,079,645 | 573,840 | 113.45% | 2,462,179 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.78% | 0.01% | 928,205 | 494,496 | 114.02% | 2,114,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.53% | 0.00% | 800,511 | 476,045 | 146.72% | 1,825,165 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.77% | 0.00% | 2,491,109 | 409,536 | 19.67% | 5,679,729 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.71% | 0.02% | 368,000 | 368,000 | 100.00% | 839,040 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.67% | 0.02% | 349,100 | 349,100 | 100.00% | 795,948 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.39% | 0.00% | 1,245,180 | 341,480 | 37.79% | 2,839,010 | Jun 30, 2024 |
| MORGAN STANLEY | 0.77% | 0.00% | 401,481 | 226,144 | 128.98% | 915,376 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.76% | 0.02% | 398,043 | 206,900 | 108.24% | 907,538 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.38% | 0.03% | 199,963 | 199,963 | 100.00% | 455,916 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 0.38% | 0.01% | 199,358 | 199,358 | 100.00% | 454,536 | Jun 30, 2024 |
| STRS OHIO | 0.37% | 0.00% | 192,700 | 192,700 | 100.00% | 439,356,000 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.34% | 0.00% | 177,051 | 177,051 | 100.00% | 403,676 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 1.10% | 0.01% | 576,354 | 162,775 | 39.36% | 1,314,087 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.61% | 0.01% | 320,800 | 141,400 | 78.82% | 731,424 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.26% | 0.00% | 133,230 | 133,230 | 100.00% | 303,764 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.26% | 0.00% | 137,921 | 116,405 | 541.02% | 314,460 | Jun 30, 2024 |
As of Jun 30 2024, G1 Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 2.41M stocks of GTHX, valued at $7.03M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -445,912 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -400,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.15% | - | 78,361 | -300,650 | -79.32% | 178,663 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.40% | 0.00% | 210,623 | -237,338 | -52.98% | 480,220 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -228,910 | -100.00% | - | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -178,600 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -175,783 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | 0.24% | 0.00% | 127,723 | -147,635 | -53.62% | 291,208 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -140,909 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -105,156 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -86,100 | -100.00% | - | Jun 30, 2024 |
| RMB CAPITAL MANAGEMENT, LLC | - | - | - | -70,795 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -47,545 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -34,648 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.04% | - | 21,029 | -33,605 | -61.51% | 47,946 | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -27,250 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -26,703 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.59% | 0.00% | 308,825 | -25,306 | -7.57% | 704,121 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -20,042 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.47% | 0.00% | 767,066 | -18,193 | -2.32% | 1,748,910 | Jun 30, 2024 |
As of Jun 30 2024, G1 Therapeutics's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -0.45M shares of GTHX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | 2.61% | 0.03% | 1,362,354 | 1,362,354 | 100.00% | 3,106,167 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.71% | 0.02% | 368,000 | 368,000 | 100.00% | 839,040 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.67% | 0.02% | 349,100 | 349,100 | 100.00% | 795,948 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.38% | 0.03% | 199,963 | 199,963 | 100.00% | 455,916 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 0.38% | 0.01% | 199,358 | 199,358 | 100.00% | 454,536 | Jun 30, 2024 |
| STRS OHIO | 0.37% | 0.00% | 192,700 | 192,700 | 100.00% | 439,356,000 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.34% | 0.00% | 177,051 | 177,051 | 100.00% | 403,676 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.13% | - | 66,928 | 66,928 | 100.00% | 152,596 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.09% | 0.02% | 46,728 | 46,728 | 100.00% | 106,540 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.09% | 0.00% | 44,500 | 44,500 | 100.00% | 101,000 | Jun 30, 2024 |
| INVESCO LTD. | 0.07% | - | 35,709 | 35,709 | 100.00% | 81,416 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 26,547 | 26,547 | 100.00% | 60,793 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.04% | - | 22,340 | 22,340 | 100.00% | 50,935 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.04% | 0.00% | 20,986 | 20,986 | 100.00% | 47,848 | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 20,220 | 20,220 | 100.00% | 46,102 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.04% | 0.00% | 19,400 | 19,400 | 100.00% | 44,232 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.03% | - | 17,076 | 17,076 | 100.00% | 38,933 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.03% | 0.00% | 15,321 | 15,321 | 100.00% | 34,932 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.03% | 0.00% | 15,200 | 15,200 | 100.00% | 34,656 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.02% | 0.51% | 12,864 | 12,864 | 100.00% | 2,932,992 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | 0.02% | - | 12,338 | 12,338 | 100.00% | 28,131 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.02% | 0.49% | 12,248 | 12,248 | 100.00% | 2,792,544 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 5,467 | 5,467 | 100.00% | 12,383 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 4,834 | 4,834 | 100.00% | 11,022 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 4,642 | 4,642 | 100.00% | 11,000 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 3,575 | 3,575 | 100.00% | 8,151 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 1,707 | 1,707 | 100.00% | 4,000 | Jun 30, 2024 |
| MFA WEALTH ADVISORS, LLC | 0.00% | 0.00% | 1,463 | 1,463 | 100.00% | 3,336 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | 0.00% | - | 350 | 350 | 100.00% | 865 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | 0.00% | 0.00% | 320 | 320 | 100.00% | 730 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.00% | - | 300 | 300 | 100.00% | 684 | Jun 30, 2024 |
G1 Therapeutics's largest new institutional shareholder by number of shares is WOODLINE PARTNERS LP, purchased 1.36M shares, valued at $3.11M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -445,912 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -400,000 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -228,910 | -100.00% | - | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -178,600 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -175,783 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -140,909 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -105,156 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -86,100 | -100.00% | - | Jun 30, 2024 |
| RMB CAPITAL MANAGEMENT, LLC | - | - | - | -70,795 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -47,545 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -34,648 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -27,250 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -26,703 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -20,042 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -16,100 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -15,614 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -14,991 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -14,703 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | - | - | - | -14,450 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -14,216 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -8,800 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -1,338 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -298 | -100.00% | - | Jun 30, 2024 |
G1 Therapeutics's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -0.45M shares, valued at -, as of undefined.
G1 Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA LIFE SCIENCES INVESTORS | 0.47% | 223,377 | - | - | Mar 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.35% | 87,161 | - | - | Dec 31, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.23% | 200,492 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.12% | 44,824 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.10% | 482,062 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.09% | 789,299 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 191,143 | 71,143 | 59.29% | Mar 28, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.07% | 251,127 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 32,793 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 11,279 | - | - | Mar 28, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.06% | 189,227 | - | - | Mar 31, 2024 |
| NEEDHAM FUNDS INC | 0.05% | 105,000 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.05% | 398,426 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 100,000 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.02% | 51,946 | - | - | Jan 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 28,455 | - | - | Feb 29, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 513,118 | - | - | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,482,508 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 131,720 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 15,188 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 62,743 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.01% | 40,713 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,012 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 105,480 | - | - | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 29,639 | - | - | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 274,726 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 19,217 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 300,000 | - | - | Feb 29, 2024 |
| ETF Managers Trust | 0.01% | 43,446 | - | - | Dec 31, 2023 |
| UBS FUNDS | 0.01% | 27,273 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,187 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 36,449 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 2,012,394 | -512,828 | -20.31% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 276,904 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 50,876 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 47,376 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 11,894 | - | - | Feb 29, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 17,697 | - | - | Mar 31, 2020 |
| Humankind Benefit Corp | 0.00% | 60 | - | - | Dec 31, 2023 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 20,786 | - | - | Mar 28, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 63,995 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 411,112 | 57,361 | 16.22% | Feb 29, 2024 |
| GABELLI EQUITY TRUST INC | 0.00% | 2,000 | - | - | Dec 29, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 11,600 | - | - | Mar 31, 2024 |
| VALIC Co II | 0.00% | 48,472 | 1,934 | 4.16% | Feb 28, 2021 |
| FIDELITY COVINGTON TRUST | 0.00% | 22,774 | - | - | Jan 31, 2024 |
| JPMORGAN TRUST II | 0.00% | 1,233,467 | - | - | Feb 29, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 16,355 | - | - | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 47,798 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,920 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 147,878 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 173,169 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 24,498 | -2,132 | -8.01% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 17,755 | - | - | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 66,078 | - | - | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 3,557 | - | - | Mar 28, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 109,315 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 176,609 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 281 | - | - | Apr 30, 2021 |
| SCHWAB CAPITAL TRUST | 0.00% | 21,516 | - | - | Jan 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 8,663 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 2,063 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 14,906 | - | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 44,936 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,937 | - | - | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 1,715 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 95,375 | - | - | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 219,091 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,402 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 29,392 | 25,999 | 766.25% | Feb 29, 2024 |
| Global X Funds | 0.00% | 11,190 | - | - | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 200 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 626 | - | - | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 7,092 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,469 | 450 | 22.29% | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 308 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 1,763 | - | - | Dec 31, 2023 |
| JPMorgan Trust I | 0.00% | 205,903 | - | - | Jan 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 651 | - | - | Mar 28, 2024 |
| MML Series Investment Fund II | 0.00% | 29,753 | - | - | Dec 31, 2023 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 2,450 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 9,461 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 1,305 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 15,034 | - | - | Mar 31, 2024 |
| Ultimus Managers Trust | 0.00% | 1,306 | - | - | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 9,026 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 377 | - | - | Dec 31, 2023 |
| RUSSELL INVESTMENT CO | 0.00% | 24,933 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 11,629 | - | - | Mar 28, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 7,005 | - | - | Mar 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 177,089 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,137 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 847 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 276,710 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 20,979 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 136,391 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 65,953 | - | - | Mar 31, 2024 |
| Pacer Funds Trust | 0.00% | 2,806 | - | - | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 4,700 | - | - | Jan 31, 2024 |
| GLENMEDE FUND INC | 0.00% | 523 | - | - | Jan 31, 2024 |
G1 Therapeutics's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 223.38K shares, compromising 0.47% of its total assets.
G1 Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 32 | -65.59% |
| 31 Mar, 24 | 93 | 4.49% |
| 31 Dec, 23 | 89 | 20.27% |
| 30 Sep, 23 | 74 | -12.94% |
| 30 Jun, 23 | 85 | -15.84% |
| 31 Mar, 23 | 101 | -15.83% |
| 31 Dec, 22 | 120 | 14.29% |
| 30 Sep, 22 | 105 | 6.06% |
| 30 Jun, 22 | 99 | -15.38% |
| 31 Mar, 22 | 117 | 4.46% |
| 31 Dec, 21 | 112 | -6.67% |
| 30 Sep, 21 | 120 | -1.64% |
| 30 Jun, 21 | 122 | -8.27% |
| 31 Mar, 21 | 133 | 0.76% |
| 31 Dec, 20 | 132 | 8.20% |
| 30 Sep, 20 | 122 | 18.45% |
| 30 Jun, 20 | 103 | 3.00% |
| 31 Mar, 20 | 100 | -0.99% |
| 31 Dec, 19 | 101 | -2.88% |
| 30 Sep, 19 | 104 | 8.33% |
| 30 Jun, 19 | 96 | 2.13% |
| 31 Mar, 19 | 94 | - |
| 31 Dec, 18 | 94 | -18.97% |
| 30 Sep, 18 | 116 | 20.83% |
| 30 Jun, 18 | 96 | 3.23% |
| 31 Mar, 18 | 93 | 63.16% |
| 31 Dec, 17 | 57 | 35.71% |
| 30 Sep, 17 | 42 | 55.56% |
| 30 Jun, 17 | 27 | - |
As of 30 Jun 24, 32 institutions are holding G1 Therapeutics's shares, representing a decrease of -65.59% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,306,779 | -55.91% |
| 31 Mar, 24 | 14,305,888 | 13.36% |
| 31 Dec, 23 | 12,619,652 | 15.31% |
| 30 Sep, 23 | 10,944,376 | -29.44% |
| 30 Jun, 23 | 15,510,418 | -19.24% |
| 31 Mar, 23 | 19,206,433 | -16.66% |
| 31 Dec, 22 | 23,046,011 | 0.18% |
| 30 Sep, 22 | 23,005,347 | 15.94% |
| 30 Jun, 22 | 19,842,431 | -17.64% |
| 31 Mar, 22 | 24,092,533 | -8.63% |
| 31 Dec, 21 | 26,367,501 | -0.74% |
| 30 Sep, 21 | 26,564,689 | 7.67% |
| 30 Jun, 21 | 24,671,835 | 2.11% |
| 31 Mar, 21 | 24,163,019 | 0.11% |
| 31 Dec, 20 | 24,135,437 | -18.54% |
| 30 Sep, 20 | 29,628,613 | 2.85% |
| 30 Jun, 20 | 28,807,989 | 0.77% |
| 31 Mar, 20 | 28,588,032 | -5.33% |
| 31 Dec, 19 | 30,198,677 | 3.87% |
| 30 Sep, 19 | 29,073,155 | 3.39% |
| 30 Jun, 19 | 28,120,861 | 2.33% |
| 31 Mar, 19 | 27,480,070 | -1.55% |
| 31 Dec, 18 | 27,913,592 | 5.30% |
| 30 Sep, 18 | 26,509,424 | 14.68% |
| 30 Jun, 18 | 23,115,098 | 15.69% |
| 31 Mar, 18 | 19,980,450 | 46.93% |
| 31 Dec, 17 | 13,598,863 | 10.23% |
| 30 Sep, 17 | 12,337,295 | 23.78% |
| 30 Jun, 17 | 9,967,179 | - |
G1 Therapeutics (GTHX) has 6.31M shares outstanding as of 30 Jun 24, down -55.91% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 12.09% | 1.58% |
| 31 Mar, 24 | 27.65% | 4.66% |
| 31 Dec, 23 | 24.37% | 5.43% |
| 30 Sep, 23 | 21.18% | 2.35% |
| 30 Jun, 23 | 30.03% | 2.17% |
| 31 Mar, 23 | 37.19% | 1.33% |
| 31 Dec, 22 | 52.83% | 1.83% |
| 30 Sep, 22 | 53.75% | 2.49% |
| 30 Jun, 22 | 46.46% | 1.46% |
| 31 Mar, 22 | 56.44% | 1.43% |
| 31 Dec, 21 | 62.86% | 1.60% |
| 30 Sep, 21 | 62.68% | 1.83% |
| 30 Jun, 21 | 58.58% | 1.66% |
| 31 Mar, 21 | 59.37% | 1.46% |
| 31 Dec, 20 | 63.72% | 1.05% |
| 30 Sep, 20 | 77.95% | 1.34% |
| 30 Jun, 20 | 76.24% | 1.32% |
| 31 Mar, 20 | 75.91% | 1.17% |
| 31 Dec, 19 | 80.53% | 1.34% |
| 30 Sep, 19 | 77.44% | 1.38% |
| 30 Jun, 19 | 75.05% | 1.39% |
| 31 Mar, 19 | 73.48% | 1.31% |
| 31 Dec, 18 | 75.03% | 1.22% |
| 30 Sep, 18 | 78.36% | 1.58% |
| 30 Jun, 18 | 70.51% | 1.52% |
| 31 Mar, 18 | 68.05% | 1.22% |
| 31 Dec, 17 | 74.73% | 1.63% |
| 30 Sep, 17 | 67.79% | 1.38% |
| 30 Jun, 17 | 70.15% | - |
As of 30 Jun 24, G1 Therapeutics is held by 12.09% institutional shareholders, representing a 1.58% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 20 | -61.54% |
| 31 Mar, 24 | 52 | 18.18% |
| 31 Dec, 23 | 44 | 25.71% |
| 30 Sep, 23 | 35 | 6.06% |
| 30 Jun, 23 | 33 | -25.00% |
| 31 Mar, 23 | 44 | -35.29% |
| 31 Dec, 22 | 68 | 3.03% |
| 30 Sep, 22 | 66 | 34.69% |
| 30 Jun, 22 | 49 | 11.36% |
| 31 Mar, 22 | 44 | -13.73% |
| 31 Dec, 21 | 51 | -3.77% |
| 30 Sep, 21 | 53 | -3.64% |
| 30 Jun, 21 | 55 | -19.12% |
| 31 Mar, 21 | 68 | 7.94% |
| 31 Dec, 20 | 63 | -3.08% |
| 30 Sep, 20 | 65 | 20.37% |
| 30 Jun, 20 | 54 | - |
| 31 Mar, 20 | 54 | 8.00% |
| 31 Dec, 19 | 50 | -23.08% |
| 30 Sep, 19 | 65 | 6.56% |
| 30 Jun, 19 | 61 | 8.93% |
| 31 Mar, 19 | 56 | 3.70% |
| 31 Dec, 18 | 54 | -31.65% |
| 30 Sep, 18 | 79 | 21.54% |
| 30 Jun, 18 | 65 | -16.67% |
| 31 Mar, 18 | 78 | 85.71% |
| 31 Dec, 17 | 42 | 31.25% |
| 30 Sep, 17 | 32 | 18.52% |
| 30 Jun, 17 | 27 | - |
20 institutional shareholders have increased their position in GTHX stock as of 30 Jun 24 compared to 52 in the previous quarter (a -61.54% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 4 | -73.33% |
| 31 Mar, 24 | 15 | -48.28% |
| 31 Dec, 23 | 29 | 45.00% |
| 30 Sep, 23 | 20 | -33.33% |
| 30 Jun, 23 | 30 | -18.92% |
| 31 Mar, 23 | 37 | 19.35% |
| 31 Dec, 22 | 31 | 72.22% |
| 30 Sep, 22 | 18 | -40.00% |
| 30 Jun, 22 | 30 | -31.82% |
| 31 Mar, 22 | 44 | 18.92% |
| 31 Dec, 21 | 37 | 23.33% |
| 30 Sep, 21 | 30 | -3.23% |
| 30 Jun, 21 | 31 | -8.82% |
| 31 Mar, 21 | 34 | -22.73% |
| 31 Dec, 20 | 44 | 51.72% |
| 30 Sep, 20 | 29 | 11.54% |
| 30 Jun, 20 | 26 | -10.34% |
| 31 Mar, 20 | 29 | -12.12% |
| 31 Dec, 19 | 33 | 65.00% |
| 30 Sep, 19 | 20 | -4.76% |
| 30 Jun, 19 | 21 | 31.25% |
| 31 Mar, 19 | 16 | -46.67% |
| 31 Dec, 18 | 30 | 36.36% |
| 30 Sep, 18 | 22 | 22.22% |
| 30 Jun, 18 | 18 | 63.64% |
| 31 Mar, 18 | 11 | 37.50% |
| 31 Dec, 17 | 8 | 100.00% |
| 30 Sep, 17 | 4 | - |
| 30 Jun, 17 | - | - |
4 institutional shareholders have reduced their position in GTHX stock as of 30 Jun 24 compared to 15 in the previous quarter (a -73.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 32 | -65.59% | 6,306,779 | -55.91% | 12.09% | 1.58% | 20 | -61.54% | 4 | -73.33% |
| 31 Mar, 24 | 93 | 4.49% | 14,305,888 | 13.36% | 27.65% | 4.66% | 52 | 18.18% | 15 | -48.28% |
| 31 Dec, 23 | 89 | 20.27% | 12,619,652 | 15.31% | 24.37% | 5.43% | 44 | 25.71% | 29 | 45.00% |
| 30 Sep, 23 | 74 | -12.94% | 10,944,376 | -29.44% | 21.18% | 2.35% | 35 | 6.06% | 20 | -33.33% |
| 30 Jun, 23 | 85 | -15.84% | 15,510,418 | -19.24% | 30.03% | 2.17% | 33 | -25.00% | 30 | -18.92% |
| 31 Mar, 23 | 101 | -15.83% | 19,206,433 | -16.66% | 37.19% | 1.33% | 44 | -35.29% | 37 | 19.35% |
| 31 Dec, 22 | 120 | 14.29% | 23,046,011 | 0.18% | 52.83% | 1.83% | 68 | 3.03% | 31 | 72.22% |
| 30 Sep, 22 | 105 | 6.06% | 23,005,347 | 15.94% | 53.75% | 2.49% | 66 | 34.69% | 18 | -40.00% |
| 30 Jun, 22 | 99 | -15.38% | 19,842,431 | -17.64% | 46.46% | 1.46% | 49 | 11.36% | 30 | -31.82% |
| 31 Mar, 22 | 117 | 4.46% | 24,092,533 | -8.63% | 56.44% | 1.43% | 44 | -13.73% | 44 | 18.92% |
| 31 Dec, 21 | 112 | -6.67% | 26,367,501 | -0.74% | 62.86% | 1.60% | 51 | -3.77% | 37 | 23.33% |
| 30 Sep, 21 | 120 | -1.64% | 26,564,689 | 7.67% | 62.68% | 1.83% | 53 | -3.64% | 30 | -3.23% |
| 30 Jun, 21 | 122 | -8.27% | 24,671,835 | 2.11% | 58.58% | 1.66% | 55 | -19.12% | 31 | -8.82% |
| 31 Mar, 21 | 133 | 0.76% | 24,163,019 | 0.11% | 59.37% | 1.46% | 68 | 7.94% | 34 | -22.73% |
| 31 Dec, 20 | 132 | 8.20% | 24,135,437 | -18.54% | 63.72% | 1.05% | 63 | -3.08% | 44 | 51.72% |
| 30 Sep, 20 | 122 | 18.45% | 29,628,613 | 2.85% | 77.95% | 1.34% | 65 | 20.37% | 29 | 11.54% |
| 30 Jun, 20 | 103 | 3.00% | 28,807,989 | 0.77% | 76.24% | 1.32% | 54 | - | 26 | -10.34% |
| 31 Mar, 20 | 100 | -0.99% | 28,588,032 | -5.33% | 75.91% | 1.17% | 54 | 8.00% | 29 | -12.12% |
| 31 Dec, 19 | 101 | -2.88% | 30,198,677 | 3.87% | 80.53% | 1.34% | 50 | -23.08% | 33 | 65.00% |
| 30 Sep, 19 | 104 | 8.33% | 29,073,155 | 3.39% | 77.44% | 1.38% | 65 | 6.56% | 20 | -4.76% |
| 30 Jun, 19 | 96 | 2.13% | 28,120,861 | 2.33% | 75.05% | 1.39% | 61 | 8.93% | 21 | 31.25% |
| 31 Mar, 19 | 94 | - | 27,480,070 | -1.55% | 73.48% | 1.31% | 56 | 3.70% | 16 | -46.67% |
| 31 Dec, 18 | 94 | -18.97% | 27,913,592 | 5.30% | 75.03% | 1.22% | 54 | -31.65% | 30 | 36.36% |
| 30 Sep, 18 | 116 | 20.83% | 26,509,424 | 14.68% | 78.36% | 1.58% | 79 | 21.54% | 22 | 22.22% |
| 30 Jun, 18 | 96 | 3.23% | 23,115,098 | 15.69% | 70.51% | 1.52% | 65 | -16.67% | 18 | 63.64% |
| 31 Mar, 18 | 93 | 63.16% | 19,980,450 | 46.93% | 68.05% | 1.22% | 78 | 85.71% | 11 | 37.50% |
| 31 Dec, 17 | 57 | 35.71% | 13,598,863 | 10.23% | 74.73% | 1.63% | 42 | 31.25% | 8 | 100.00% |
| 30 Sep, 17 | 42 | 55.56% | 12,337,295 | 23.78% | 67.79% | 1.38% | 32 | 18.52% | 4 | - |
| 30 Jun, 17 | 27 | - | 9,967,179 | - | 70.15% | - | 27 | - | - | - |
G1 Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of G1 Therapeutics's stock was made by Perry Andrew on Jul 08 2024, selling 1,337 shares at $2.51 per share (valued at $3.35K).
G1 Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 6 | - | - |
| Q2 2024 | 12 | 7 | 171.43% |
| Q1 2024 | 18 | 20 | 90.00% |
| Q4 2023 | 2 | 4 | 50.00% |
| Q3 2023 | 2 | 8 | 25.00% |
| Q2 2023 | 20 | 1 | 2000.00% |
| Q1 2023 | 16 | 17 | 94.12% |
| Q4 2022 | 2 | 4 | 50.00% |
| Q3 2022 | 4 | 8 | 50.00% |
| Q2 2022 | 9 | - | - |
| Q1 2022 | 18 | 10 | 180.00% |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | 2 | 7 | 28.57% |
| Q2 2021 | 19 | 25 | 76.00% |
| Q1 2021 | 25 | 25 | 100.00% |
| Q4 2020 | 5 | 15 | 33.33% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 7 | - | - |
| Q1 2020 | 15 | 6 | 250.00% |
| Q3 2019 | 2 | 1 | 200.00% |
6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by G1 Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 7 | - |
| Q1 2024 | - | 19 | - |
| Q4 2023 | - | 2 | - |
| Q3 2023 | - | 6 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 11 | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 6 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 3 | - |
| Q2 2021 | - | 11 | - |
| Q1 2021 | - | 12 | - |
| Q4 2020 | 3 | 11 | 27.27% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q3 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of G1 Therapeutics's stocks.
G1 Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| SANA | Sana Biotechnology, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| ATRA | Atara Biotherapeutics, Inc. |
| FATE | Fate Therapeutics, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| RCUS | Arcus Biosciences, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PDSB | PDS Biotechnology Corporation |
| HOOK | HOOKIPA Pharma Inc. |
| MGNX | MacroGenics, Inc. |
| HRTX | Heron Therapeutics, Inc. |
| SGMO | Sangamo Therapeutics, Inc. |
| CRBU | Caribou Biosciences, Inc. |
| AXSM | Axsome Therapeutics, Inc. |
| ALLO | Allogene Therapeutics, Inc. |
| ANNX | Annexon, Inc. |
| PBYI | Puma Biotechnology, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| CHRS | Coherus BioSciences, Inc. |
| GRTX | Galera Therapeutics, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
GTHX Ownership FAQ
Who Owns G1 Therapeutics?
G1 Therapeutics is owned by institutional shareholders (12.09%), insiders (10.92%), and public (76.99%). The largest institutional shareholder of G1 Therapeutics is BLACKROCK INC. (5.91% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.47% of total shares).
Who are the major institutional shareholders of G1 Therapeutics?
G1 Therapeutics's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, WOODLINE PARTNERS LP, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 17.75% of the company's share outstanding.
How many G1 Therapeutics shareholders are there?
As of Jun 2024, there are 32 institutional shareholders of G1 Therapeutics.
What percentage of G1 Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 3.08M shares of G1 Therapeutics, representing 5.91% of the company's total shares outstanding, valued at $7.03M (as of Jun 2024).
What percentage of G1 Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 2.49M shares of G1 Therapeutics (GTHX), compromising 4.77% of the company, valued at $5.68M.
What percentage of G1 Therapeutics is owned by WOODLINE PARTNERS LP?
WOODLINE PARTNERS LP is the third largest holder of G1 Therapeutics. The company owns 1.36M of the company's shares outstanding (worth $3.11M).